Premalignant and Malignant Perianal Lesions
Related Experiment Video
Updated: Jan 19, 2026

Isolating Malignant and Non-Malignant B Cells from lck:eGFP Zebrafish
Published on: February 22, 2019
Mohammad Ali Abbass1, Michael A Valente1
1Department of Colorectal Surgery, Digestive Disease and Surgery Institute, Cleveland Clinic, Cleveland, Ohio.
Abstract:
Anal cancer is a heterogeneous and rare disease process that accounts for ∼1.5% of all gastrointestinal tract malignancies. The perianal skin plays host to a variety of different premalignant and malignant lesions, all with variable histology, treatment options, and prognosis. Anal cancers in general are notorious for having a delayed or missed diagnosis leading to treatment delays and may have an impact on survival. This delay is in part due to the nonspecific symptomatology and also improper physical examination of the sensitive and anatomically complex perianal region and anal canal. This article examines the various types of perianal cancers and their precursor lesions and will explore treatment options as well as outcomes and prognosis.
Related Concept Videos
08:32Isolating Malignant and Non-Malignant B Cells from lck:eGFP Zebrafish
05:24Multifractal Spectrum Analysis for Assessing Pulmonary Nodule Malignancy
10:21A Coregistered Ultrasound and Photoacoustic Imaging Protocol for the Transvaginal Imaging of Ovarian Lesions
09:39Normal and Malignant Muscle Cell Transplantation into Immune Compromised Adult Zebrafish
08:16Comparative Lesions Analysis Through a Targeted Sequencing Approach
07:44Endoscopic Ultrasound-Guided Biliary Drainage: Endoscopic Ultrasound-Guided Hepaticogastrostomy in Malignant Biliary Obstruction

